Bliss Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 17-12-2024
- Paid Up Capital ₹ 0.30 M
as on 17-12-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 8.92%
(FY 2017)
- Profit 295.60%
(FY 2017)
- Ebitda 107.35%
(FY 2017)
- Net Worth 4.69%
(FY 2017)
- Total Assets 16.67%
(FY 2017)
About Bliss Ayurveda
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Agrawal and Smita Aggarwal serve as directors at the Company.
- CIN/LLPIN
U24233DL2006PTC149579
- Company No.
149579
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bliss Ayurveda Private Limited. offer?
Bliss Ayurveda Private Limited. offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Common Disease Medicines, Pharmaceutical Tablets, Ayurvedic & Herbal Health Supplement, Herbal Supplements, Pharmaceutical Capsules, Medical Surgery & Treatment Centres.
Who are the key members and board of directors at Bliss Ayurveda?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Agrawal  | Director | 09-Jun-2006 | Current |
| Smita Aggarwal | Director | 13-Dec-2011 | Current |
Financial Performance of Bliss Ayurveda.
Bliss Ayurveda Private Limited., for the financial year ended 2017, experienced modest growth in revenue, with a 8.92% increase. The company also saw a substantial improvement in profitability, with a 295.6% increase in profit. The company's net worth moved up by a moderate rise of 4.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bliss Ayurveda?
In 2017, Bliss Ayurveda had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bliss Ayurveda (India) Private LimitedActive 16 years 3 monthsNitin Agrawal and Smita Aggarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bliss Ayurveda?
Unlock and access historical data on people associated with Bliss Ayurveda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bliss Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bliss Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
